Cyclerion Therapeutics (NASDAQ:CYCN) issued its quarterly earnings data on Monday. The company reported ($1.18) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.84) by ($0.34), Bloomberg Earnings reports. The company had revenue of $1.63 million for the quarter.
Shares of NASDAQ:CYCN opened at $8.32 on Tuesday. Cyclerion Therapeutics has a 1 year low of $8.14 and a 1 year high of $21.00. The stock has a fifty day simple moving average of $10.87.
Separately, Credit Suisse Group began coverage on shares of Cyclerion Therapeutics in a report on Monday, June 3rd. They issued a “neutral” rating for the company.
There is no company description available for Cyclerion Therapeutics Inc
Read More: Investing in Growth Stocks
Receive News & Ratings for Cyclerion Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyclerion Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.